Pacific Biosciences of California, Inc. (PACB)

1.61 -0.07 (-4.17%) USD  |  NASDAQ  |  Feb 20, 16:00
1.615 0.00 (0.00%) After-Hours: 20:00
More

Pacific Biosciences of California Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Boston Scientific Corp. Upgrade
Intellia Therapeutics, Inc. Upgrade
Enovis Corp. Upgrade